Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT03708952
Active, not recruiting Observational

Lifestyle and Dietary Pattern in Relation to Precursor Lesions of Colorectal Cancer and Cardiometabolic Diseases

NCT03708952 · tracked via the Priya Life Science China tracker
Sponsor
Zhejiang University
Phase
Observational
Started
2018-05-01
Last updated
2024-01-10

Condition(s) studied

PolypsCardiovascular Diseases

Study summary

The association between lifestyle and dietary patterns with precursor lesions of colorectal cancer and cardiometabolic diseases is still unclear. This study is conducted in Jinhua, a city with a high prevalence of colorectal cancer in China, to assess the relationship between lifestyle and dietary factors with precursor lesions of colorectal cancer and cardiometabolic diseases.

Eligibility

Sex
ALL
Min age
45 Years
Max age
74 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Subject aged ≥45 and ≤74 years old * Subject has complete data on diet and follow-up time Exclusion Criteria: * Colorectal cancer * Severe intestines problems

Primary outcome measure(s)

  • Numbers of participants with polyps — From entry into the study (baseline:2018-2022) until 2028
    All polyps

Trial sites (2)

FacilityCityRegionStatus
Lanxi Hospital of Traditional Chinese Medicine Jinhua Zhejiang
Lanxi Red Cross Hospital Lanxi Zhejiang

More Zhejiang University trials in China

Video Double-Lumen Tube for Secondary Pulmonary Resection Starting soon
Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic Leukemia Active, not recruiting
Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC) Recruiting
Precision Nutrition and Food Safety for Dietary Prevention of Chronic Disease Study Active, not recruiting
Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two-Stage Phase II Clinical Study Recruiting

Other trials for the same condition

Factors Associated With Posttransplant Cardiac Outcomes Recruiting
Cardiovascular Risk Assessment and Dynamic Monitoring-based Prevention Trial Recruiting
Effects of Non-surgical Periodontal Therapy on Cardiovascular Risk Starting soon
Protective Effect of RIPC Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery (Panda VII) Starting soon
Cardiovascular Risk Early Screening and Warning in Harbin : A Prospective Cohort Study Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03708952 on ClinicalTrials.gov ↗ ← All trials in China